Procyrion Appoints Jason Whiting as CEO Following Leadership Transition
1 day ago
1 min read
Houston, TX, November 17, 2026 (PR Newswire) -- Procyrion, Inc., a medical device company developing innovative circulatory support technologies for patients with advanced heart failure, has appointed Jason Whiting as its new Chief Executive Officer. Whiting succeeds the company's outgoing leadership as Procyrion enters its next phase of development and commercialization. He brings extensive executive leadership experience in the medical device industry, including expertise in business development, operations, and bringing innovative cardiovascular technologies to market.
Read full article here.






















Comments